Navigation Links
USC scientist's revolutionary drug pump draws NSF support

Last month, for the first time in 11 years, USC Associate Professor Ellis Meng found herself raising her hand and asking questions in the classroom not answering them.

Meng, whose research at USC focuses on developing a tiny, implantable medication-delivery system, is enrolled in a business crash-course sponsored by the National Science Foundation, learning how to understand customers, develop viable business models, and get on the fast track to becoming a commercial product.

She was selected to receive the NSF's new Innovation Corps award. The award is designed to help researchers get innovative ideas out of the lab and into the real world.

"It's supposed to kick-start the effort," said Meng, who teaches biomedical and electrical engineering at the USC Viterbi School of Engineering.

A couple weeks ago, she and her team flew to Stanford University to attend a three-day business bootcamp.

"We were sort of fed through the firehose," Meng said. Now back in Los Angeles, she is continuing her education online. In December, Meng's team and 20 others that have been selected by the NSF will pitch their products and newly developed business strategies for marketing them to a room full of potential investors.

Meng's team was among the NSF's first cohort to receive the six-month, $50,000 award.

Each team includes a principle investigator, a student or post doc, and an industry mentor. Meng is working with Christian Gutierrez, a recent Viterbi PhD graduate; Tuan Hoang, a Viterbi lecturer; and Carol Christopher, an industry expert and mentor.

She joked that the program is designed to "help you fail quickly" that is, to spend a minimum of time and resources figuring out whether a product being developed by a researcher has a potential to succeed commercially in a specific market, or whether it needs to be applied to a different market or reimagined.

The course has already offered useful insights into Meng's drug delivery pump, which is designed to address chronic conditions that require long term, localized use of drugs such as cancer, epilepsy, and chronic pain.

Because of its tiny size smaller in diameter than a dime, and as thick as a short stack of quarters the pump can also be used in animal studies, unlike older designs.

Currently, similar pumps are bulky, which makes them difficult to implant inconspicuously, particularly in children. Meng's pump enjoys a much better volume efficiency, meaning that the bulk of the device is taken up by the medication it delivers, as opposed to complicated mechanical pumps or batteries.

Part of that is due to the fact that the pump does not require large batteries it is the first drug pump that can be powered up and operated wirelessly. With the I-Corps award, Meng hopes to see her invention realized as a commercial product soon.

"The timing was perfect," she said. "I'm happy that the NSF is so forward thinking and pioneered a program like this. Through this effort, we can work together to make sure technologies are not orphaned in the laboratory."


Contact: Robert Perkins
University of Southern California

Related biology news :

1. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
2. Scientists identify novel inhibitor of human microRNA
3. Argonne scientists peer into heart of compound that may detect chemical, biological weapons
4. MU scientists go green with gold, distribute environmentally friendly nanoparticles
5. Scientists identify gene that may contribute to improved rice yield
6. Scientists discover why a mothers high-fat diet contributes to obesity in her children
7. MU scientists see how HIV matures into an infection
8. Earth scientists keep an eye on Texas
9. Thinking it through: Scientists call for policy to guide biofuels industry toward sustainability
10. Scientists identify a molecule that coordinates the movement of cells
11. Scientists Find new migratory patterns for Mediterranean and Western Atlantic bluefin tuna
Post Your Comments:
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
(Date:6/23/2016)... adds 2016 global ... pharmaceuticals section with historic and forecast data along ... Complete report on the Cell Culture ... companies and supported with 261 tables and figures ... The Global Cell Culture Media Industry ...
Breaking Biology Technology: